<bill session="115" type="s" number="2885" updated="2019-05-01T14:27:31Z">
  <state datetime="2018-05-17">REFERRED</state>
  <status>
    <introduced datetime="2018-05-17"/>
  </status>
  <introduced datetime="2018-05-17"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.</title>
    <title type="short" as="introduced">Disclosing Pharmaceutical Company Windfall Profits Act of 2018</title>
    <title type="short" as="introduced">Disclosing Pharmaceutical Company Windfall Profits Act of 2018</title>
    <title type="display">Disclosing Pharmaceutical Company Windfall Profits Act of 2018</title>
  </titles>
  <sponsor bioguide_id="S001203"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2018-06-13"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-17">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-05-17" state="REFERRED">
      <text>Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSBK" name="Senate Banking, Housing, and Urban Affairs" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Finance and financial sector"/>
  </subjects>
  <amendments/>
  <summary date="2018-05-17T04:00:00Z" status="Introduced in Senate">Disclosing Pharmaceutical Company Windfall Profits Act of 2018 

This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development.</summary>
  <committee-reports/>
</bill>
